This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why Investors Should Retain Fiserv (FISV) Stock Now
by Zacks Equity Research
The recent acquisition of Finxact is expected to expand Fiserv's (FISV) account processing, digital and payments solutions.
Are Options Traders Betting on a Big Move in Cross Country (CCRN) Stock?
by Zacks Equity Research
Investors need to pay close attention to Cross Country (CCRN) stock based on the movements in the options market lately.
FTI Consulting (FCN) Rides on Low Debt, Investor-Backing Moves
by Zacks Equity Research
FTI Consulting's (FCN) stock is aided by a solid capital position and shareholder-friendly strategies.
Insperity (NSP) Announces a Dividend Hike, Cheers Investors
by Zacks Equity Research
Insperity's (NSP) shareholder-friendly move of approving a dividend raise not only instills investors' confidence in the stock but also positively impacts its earnings per share.
Reasons Why You Should Bet on Charles River (CRAI) Stock
by Zacks Equity Research
Solid business diversification and investor-friendly moves aid Charles River (CRAI) stock.
Republic Services' (RSG) Acquisitions Aid Despite Debt Burden
by Zacks Equity Research
Republic Services' (RSG) top line benefits from the favorable impact of its inorganic growth profile and organic strength. However, its debt load remains a woe.
Here's Why You Should Retain TransUnion (TRU) Stock for Now
by Zacks Equity Research
TransUnion's (TRU) gigantic treasure trove of data is its most distinguishing asset and also perhaps the biggest barrier to entry for competitors.
5 Broker-Friendly Stocks to Tide Over the Market Doldrums
by Maharathi Basu
We believe that broker-favorite stocks like Cross Country Healthcare (CCRN), American Airlines (AAL), ArcBest (ARCB), Clearwater Paper (CLW) and Avnet (AVT) should be on an investor's radar.
S&P Global (SPGI) Gains From Acquisitions Despite High Debt
by Zacks Equity Research
S&P Global's (SPGI) acquisition strategy to innovate, increase differentiated content and develop new products looks impressive.
Here's Why You Should Hold on to Envestnet (ENV) Stock for Now
by Zacks Equity Research
Envestnet's (ENV) business model ensures solid asset-based and subscription-based recurring revenue generation capacity.
5 Reasons Why You Should Invest in FTI Consulting (FCN) Stock
by Zacks Equity Research
FTI Consulting's (FCN) international operations should help expand its geographic footprint and contribute to top-line growth.
Here's Why You Should Retain WEX Stock in Your Portfolio
by Zacks Equity Research
WEX's strong organic growth and revenue stability boost the stock.
Reasons to Retain Trane Technologies (TT) in Your Portfolio
by Zacks Equity Research
Trane Technologies (TT) remains focused on improving its business operating system and innovation through business transformation initiatives.
Insperity (NSP) Up on Worksite Employee Growth, Expenses Ail
by Zacks Equity Research
Insperity's (NSP) top line continues to benefit from an increase in average number of worksite employees paid per month.
Reasons to Retain FLEETCOR Technologies (FLT) in Your Portfolio
by Zacks Equity Research
FLEETCOR's (FLT) top line continues to grow organically, driven by continued strong sales, robust retention levels and healthy same-store sales.
Verisk (VRSK) Riding on Growth Strategies, Debt Woes Stay
by Zacks Equity Research
Verisk (VRSK) remains focused on organic growth, product development and acquisitions.
Broadridge (BR) Rides on Recurring Revenues, Debt Woes Persist
by Zacks Equity Research
Broadridge (BR) has a robust business model that ensures significant recurring-fee revenues. A debt-laden balance sheet is concerning.
Automatic Data Processing (ADP) Rides on Buyouts, Debt Ails
by Zacks Equity Research
Automatic Data Processing's (ADP) top-line benefits from the favorable impact of acquisitions.
Cross Country Healthcare and AnheuserBusch InBev have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Cross Country Healthcare and AnheuserBusch InBev are part of Zacks Bull and Bear of the Day article.
Bull Of The Day: Cross Country Healthcare (CCRN)
by Brian Bolan
A low single digit forward PE and outstanding growth too? Yes please, more of that!
FactSet (FDS) Stock Up 13.8% in a Year: What's Behind It?
by Zacks Equity Research
Consecutive better-than-expected top and bottom-line performance, shareholder-friendly moves and encouraging guidance have been benefiting the FactSet (FDS) stock.
IQVIA (IQV) Strong on IT Infrastructure Despite Debt Woes
by Zacks Equity Research
IQVIA (IQV) rides on a solid healthcare-specific global IT infrastructure and analytics-driven clinical development skills. However, a weak balance sheet is worrisome.
ICF International (ICFI) Banks on Prudent Strategies as Costs Ail
by Zacks Equity Research
The recent acquisition of Creative Systems and Consulting expands ICF International's (ICF) federal IT modernization/digital transformation capabilities.
H&R Block (HRB) Banks on Five-Year Strategy Amid Cost Pressures
by Zacks Equity Research
The main drivers of H&R Block's (HRB) post-pandemic performance can be digital enablement of its business, client addition and retention in Assisted and DIY, and greater usage of AI.
Zacks Value Trader Highlights: Bunge Limited, Titan International, Penske Automotive Group, Beazer Homes and Cross Country Healthcare
by Zacks Equity Research
Bunge Limited, Titan International, Penske Automotive Group, Beazer Homes and Cross Country Healthcare zacks Zacks Value Trader blog.